1-3 of 3
Keywords: Prognostic biomarker
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Exosome-Derived miR-148a-3p Protect against Tumor Proliferation and Metastasis of Esophageal Squamous Carcinoma

Available to Purchase
Subject Area:
Oncology
Jingting Zhang, Takeshi Toyozumi, Masayuki Kano, Yasunori Matsumoto, Ryota Otsuka, Nobufumi Sekino, Tadashi Shiraishi, Koichiro Okada, Toshiki Kamata, Shinichiro Iida, Hiroki Morishita, Tenshi Makiyama, Yuri Nishioka, Masanari Yamada, Masaya Uesato, Koichi Hayano, Akira Nakano, Hisahiro Matsubara
Journal: Oncology
Oncology (2025)
https://doi.org/10.1159/000544987
Published Online: 11 March 2025
..., instructions or products referred to in the content or advertisements. 2025 Esophageal squamous cell carcinoma Exosome Metastasis Survival miR-148a-3p Prognostic biomarker Esophageal cancer (EC) is the sixth deadliest malignancy in the world, which seriously threatens human health [ 1...
View articletitled, Exosome-Derived miR-148a-3p Protect against Tumor Proliferation and Metastasis of Esophageal Squamous Carcinoma
Open the PDF for Exosome-Derived miR-148a-3p Protect against Tumor Proliferation and Metastasis of Esophageal Squamous Carcinoma in another window
Journal Articles

GNRI Sustainability during One Cycle of First-Line Chemotherapy as a Prognostic Indicator in Patients with Metastatic Urothelial Carcinoma

Available to Purchase
Subject Area:
Topic Article Package: ADC (Antibody-Drug Conjugates) , Karger e-Journal Backfile Collection 2023 , Oncology
Yosuke Sugiyama, Taku Naiki, Yoshihiko Tasaki, Yoshihisa Mimura, Toshiki Etani, Yusuke Noda, Satoshi Nozaki, Nobuhiko Shimizu, Rika Banno, Takashi Nagai, Teruki Isobe, Ryosuke Ando, Yoshinobu Moritoki, Tomoya Kataoka, Kunihiro Odagiri, Maria Aoki, Masakazu Gonda, Takahiro Yasui, Yoko Hibi
Journal: Oncology
Oncology (2023) 101 (4): 224–233.
https://doi.org/10.1159/000529203
Published Online: 20 April 2023
... carcinoma Prognostic biomarker Urothelial carcinoma (UC) is a highly malignant cancer that predominantly affects the elderly. This disease is chemosensitive [ 1 ]; the gold standard treatment for those with advanced or metastatic UC (mUC) is platinum-based systemic chemotherapy [ 2‒7 ]. Although...
View articletitled, GNRI Sustainability during One Cycle of First-Line Chemotherapy as a Prognostic Indicator in Patients with Metastatic Urothelial Carcinoma
Open the PDF for GNRI Sustainability during One Cycle of First-Line Chemotherapy as a Prognostic Indicator in Patients with Metastatic Urothelial Carcinoma in another window
Journal Articles

TUBB3 Is Associated with High-Grade Histology, Poor Prognosis, p53 Expression, and Cancer Stem Cell Markers in Clear Cell Renal Cell Carcinoma

Available to Purchase
Subject Area:
Oncology
Yohei Sekino, Xiangrui Han, Takashi Babasaki, Shunsuke Miyamoto, Hiroyuki Kitano, Go Kobayashi, Keisuke Goto, Shogo Inoue, Tetsutaro Hayashi, Jun Teishima, Naoya Sakamoto, Kazuhiro Sentani, Naohide Oue, Wataru Yasui, Akio Matsubara
Journal: Oncology
Oncology (2020) 98 (10): 689–698.
https://doi.org/10.1159/000506775
Published Online: 25 June 2020
...(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. Renal cell carcinoma TUBB3 Prognostic biomarker p53 Cancer stem cell Renal cell carcinoma (RCC) was the twelfth...
View articletitled, TUBB3 Is Associated with High-Grade Histology, Poor Prognosis, p53 Expression, and Cancer Stem Cell Markers in Clear Cell Renal Cell Carcinoma
Open the PDF for TUBB3 Is Associated with High-Grade Histology, Poor Prognosis, p53 Expression, and Cancer Stem Cell Markers in Clear Cell Renal Cell Carcinoma in another window